Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: An effective regimen with low procedure-related toxicity

British Journal of Haematology

Volumn 108, Issue 4, 2000, Pages 754-760

  Cull, G M ^a   Haynes, A P ^a   Byrne, J L ^a   Carter, G I ^a   Miflin, G ^a   Rebello, P ^b   Hale, G ^b   Waldmann, H ^b   Russell, N H ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Allogeneic transplantation; BEAM; CAMPATH; Lymphoma

Indexed keywords

CARMUSTINE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; MELPHALAN; METHOTREXATE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; MALE; MORTALITY; PRIORITY JOURNAL; RELAPSE; STEM CELL TRANSPLANTATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CYCLOSPORINE; CYTARABINE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MALE; MELPHALAN; METHOTREXATE; MIDDLE AGED; PODOPHYLLOTOXIN; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034027095     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01879.x     Document Type: Article

References (27)

1. Anderson, J.E., Litzow, M.R., Applebaum, F.R., Schoch, G., Fisher, L.D., Buckner, C.D., Petersen, F.B., Crawford, S.W., Press, O.W., Sanders, J.E., Bensinger. W.I., Martin, P.J., Storb, R., Sullivan, K.M., Hansen, J.A. & Thomas, E.D. (1993) Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience. Journal of Clinical Oncology. 11, 2342-2350.
2. Bowen, A.L., Zomas, A., Emmett, E., Matutes, E., Dyer, M.J.S. & Catovsky, D. (1997) Subcutaneous CAMPATH-1H in fludarabine resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia. British Journal of Haematology, 96, 617-619.
3. Byrne, J.L., Stainer, C., Hyde, H., Miflin, G., Haynes, A.P., Bessell, E.M. & Russell, N.H. (1998) Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis, Bone Marrow Transplantation, 22, 541-545.
4. Chopra, R., Goldstone, A.H., Pearce, R., Philip, T., Petersen, F., De Applebaum, F., Vol. E. & Ernst. P. (1992) Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group registry data. Journal of Clinical Oncology, 10, 1690-1695.
5. Chopra, R., McMillan, A.K., Linch, D.C., Yuklea, S., Taghipour, G., Pearce, R., Patterson, K.G. & Goldstone, A.H. (1993) The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor risk Hodgkin's disease. A single centre 8 year study of 155 patients. Blood 81, 1137-1145.
6. Demirer, T., Weaver, C.H., Buckner, C.D., Petersen, F.B., Bensinger, W.I., Sanders, J., Clift, R.A., Lilleby, K., Anasetti, C., Martin, P., Storb, R., Chauncey, T., Doney, K., Sullivan, K. & Applebaum, F.R. (1995) High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy. Journal of Clinical Oncology. 13, 596-602.
7. Freedman, A.S., Gribben, J.G., Neuberg, D., Mauch, P., Soiffer, R.J., Anderson, K.C., Pandite, L., Robertson, M.J., Kroon, M., Ritz, J. & Nadler, L.M. (1996) High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood, 88, 2780-2786.
8. Gajewski, J.L., Phillips, G.L., Sobocinski, K.A., Armitage, J.O., Gale, R.P., Champlin, R.E., Herzig, R.H., Hurd, D.D., Jagannath, S., Klein, J.P., Lazarus, H.M., McCarthy, P.L., Pavlovsky, S., Petersen, F.B., Rowlings, P.A., Russell, J.A., Silver, S.M., Vose, J.M., Wiernik, P.H., Bortin, M.M. & Horowitz, M.M. (1996) Bone marrow transplantation from HLA-identical siblings in advanced Hodgkin's disease. Journal of Clinical Oncology, 14, 572-578.
9. Hale, G., Cobbold, S.P., Waldmann, H., Easter, G., Matejtschuk, P. & Coombs, R.R.A. (1987) Isolation of low-frequency class-switch variants from rat hybrid myeloma. Journal of Immunological Methods, 103, 59-67.
10. Hamblin, M., Marsh, J.C.W., Lawler, M., McCann, S.R., Wickham, N., Dunlop, L., Ball, S., Davies, E.G., Hale, G., Waldmann, H. & Gordon-Smith, E.C. (1996) Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors. Bone Marrow Transplantation, 17, 819-824.
11. Jones, R.J., Piantedosi, S., Mann, R.B., Ambinder, R.F., Seifter, E.J., Vriesendorp, H.M., Abeloff, M.D., Burns, W.H., May, W.S., Rowley, S.D., Vogelsang, G.B., Wagner, J.E., Wiley, J.M., Wingard, J.R., Yeager, A.M., Saral, R. & Santos, G.W. (1990) High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease. Journal of Clinical Oncology. 8, 527-537.
12. Khouri, I.F., Keating, M., Korbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., Giralt, S., Ippoloti, C., von Wolff, B., Gajewski, J., Donato, M., Claxton, D., Ueno, N., Andersson, B., Gee, A. & Champlin, R. (1998) Transplant-Lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. Journal of Clinical Oncology. 16, 2817-2824.
13. LaPorte, J., Fouillard, L., Douay, L., Eugene-Jolchine, I., Isnard, F., Stachowiak, J., Najman, A. & Gorin, N.C. (1991) GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen. Lancet, 338, 601-602.
14. Lundin, J., Osrerborg, A., Brittinger, G., Crowther, D., Engert, A., Epenetos, A., Gisselbrecht, C., Huhn, D., Jaeger, U., Thomas, J., Marcus, R., Nissen, N., Poynton, C., Rankin, E., Stahel, R., Uppenkamp, M., Willemze, R. & Mellstedt, H. (1998) CAMPATHIH monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. Journal of Clinical Oncology. 16, 3257-3263.
15. Miflin, G., Stainer, C.J., Carter, G.I., Byrne, J.L. & Russell, N.H. (1999) Comparative serial quantitative measurements of chimaerism following unmanipulated allogeneic transplantation of peripheral blood stem cells and bone marrow. British Journal of Haematology, 107, 429-440.
16. Milpied, N., Fielding, A., Pearce, R.M., Renst, P. & Golstone, A. (1996) Allogeneic bone marrow transplantation is not better than autologous transplantation for patients with relapsed Hodgkin's disease. Journal of Clinical Oncology. 14, 1291-1296.
17. Osterborg, A., Dyer, M.J.S., Bunjes, D., Pangalis, G.A., Bastion, Y., Catovsky, D. & Mellstedt, H. (1997) Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukaemia. Journal of Clinical Oncology. 15, 1567-1574.
18. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lilie, H., Bron, D., Sonnenveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier, B., Biron, P., Mandelli, F. & Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540-1545.
19. Przepiorka, D., van Biesen, K., Khouri, I., Hagemeister, F., Samuels, B., Folloder, J., Ueno, N.T., Molldrem, J., Mehra, R., Korbling, M., Giralt, S., Gajewski, J., Donato, M., Cleary, K., Claxton, D., Braunschweig, I., Andersson, B., Anderlini, P. & Champlin, R. (1998) Phase II study of BCNU, etoposide. ARA-C, melphalan (BEAM) and HLA-identical allogeneic marrow or blood stem cell transplantation for primary refractory or relapsed lymphoma. Blood, 92, 287a.
20. Ratanatharathorn, V., Uberti, J., Karanes, C., Abella, E., Lum, L.G., Momin, F., Cummings, G. & Sensenbrenner, L.L. (1994) Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood, 84, 1050-1055.
21. Recce, D.E., Connors, J.M., Spinelii, J.J., Barnett, M.J., Fairey, R.N., Klingemann, H.G., Nantel, S.H., O'Reilly, S., Shepherd, J.D., Sutherland, H.J., Voss, N., Chan, K.W. & Phillips, G.L. (1994) Intensive therapy with cyclophosphamide, carmustine, etoposide +/-cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood, 83, 1193-1199.
22. Salisbury, J.R., Rapson, N.T., Codd, J.D., Rogers, M.V. & Nethersell, A.B.W (1994) Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas. Journal of Clinical Pathology. 47, 313-317.
23. Singhal, S., Powles, R., Treleaven, J., Horton, C., Swansbury, G.J. & Mehta, J. (1996) Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women. Bone Marrow Transplantation, 18, 1049-1055.
24. Van Besien, K., Demuynck, H., Lemaistre, C.F., Bogaerts, M.A. & Champlin, R. (1995) High-dose melphalan allows durable engraftment of allogeneic bone marrow. Bone Marrow Transplantation, 15, 321-323.
25. Van Besien, K., Mehra, R.C., Giralt, S.A., Kantarjian, H.M., Pugh. W.C., Khouri, I.F., Moon, Y., Williams, P., Andersson, B.S., Przepiorka, D., McCarthy, P.L., Gajewski, J.L., Deisseroth, A.B., Cabanillas, F.F. & Champlin, R. (1996) Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity, and survival depend on disease histology. American Journal of Medicine. 100, 299-307.
26. Van Besien, K., Sobocinski, A., Rowlings, P.A., Murphy, S.C., Armitage, J.O., Bishop, M.R., Chaekal, O.K., Gale, R.P., Klein, J.P., Lazarus, H.M., McCarthy, P.L., Raemaekers, J.M., Reiffers, J., Phillips, G.L., Schattenberg, A., Verdonck, L.F., Vose, J.M. & Horowitz, M.M. (1998) Allogeneic bone marrow transplantation for low-grade lymphoma. Blood, 92, 1832-1836.
27. Verdonck, L.F., Dekker, A.W., Lokhorst, H.M., Petersen, E.J. & Nieuwenhuis, H.K. (1997) Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood, 90, 4201-4205 .